Ethics Review of Biomedical Research in Uzbekistan: Policy and Program Gaps

被引:0
作者
Aniyozova, Dilfuza [1 ]
Strosberg, Martin A. [2 ]
机构
[1] Tashkent Inst Postgrad Med Educ, Tashkent, Uzbekistan
[2] Clarkson Univ, Schenectady, NY USA
关键词
Research ethics; Ethics review; IRB; Biomedical research; Uzbekistan;
D O I
10.1007/s41649-023-00273-2
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
We describe the national health research ethics review system of Uzbekistan and identify policy and program gaps that impede the protection of human research subjects. We find that the National Ethic Committee (NEC), functioning at the national level, is solely responsible for conducting research ethics review. There is little evidence that regional ethics committees work as intended, and there is no research ethics review at medical institutes and research centers even though they conduct CDTs (clinical drug trials). There is no national policy for the ethical review of non-clinical trials. We recommend the establishment of institutional review boards (IRBs) at medical institutes and research centers while at the same time building capacity at the national level to oversee and support the research ethics review system of the entire country.
引用
收藏
页码:653 / 661
页数:9
相关论文
共 15 条
  • [1] Abdurakhmanova N., 2020, FACE FACE INTERVIEW
  • [2] Aniyozova D., 2020, INT C ETH REG ISS HL
  • [3] AVUZ, 2020, BIOETH COMM ASS PHYS
  • [4] Non-equivalent stringency of ethical review in the Baltic States: a sign of a systematic problem in Europe?
    Gefenas, E.
    Dranseika, V.
    Cekanauskaite, A.
    Hug, K.
    Mezinska, S.
    Peicius, E.
    Silis, V.
    Soosaar, A.
    Strosberg, M.
    [J]. JOURNAL OF MEDICAL ETHICS, 2010, 36 (07) : 435 - 439
  • [5] Moving from research ethics review to research ethics systems in low-income and middle-income countries
    Hyder, Adrian A.
    Dawson, Liza
    Bachani, Abdulgafoor M.
    Lavery, James V.
    [J]. LANCET, 2009, 373 (9666) : 862 - 865
  • [6] ICH. International Council for Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, GUID GOOD CLIN PRACT
  • [7] Kubar O., 2010, CURRENT STATE BIOETH, P24
  • [8] Lex.U, 2015, LAW REP UZB PHARM PR
  • [9] Lex.U, 2023, LAW REP UZB PROT CIT
  • [10] MoH, 2018, ETH COD UZB PHYS INV